Enhanced bioavailability of verapamil after oral administration with hesperidin in rats

Archives of Pharmacal Research

Volumn 31, Issue 4, 2008, Pages 518-522

  Piao, Yong Ji ^a   Choi, Jun Shik ^a  

^a Chosun University   (South Korea)

Author keywords

Bioavailability; Hesperidin; Norverapamil; Pharmacokinetics; Rats; Verapamil

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DRUG DERIVATIVE; HESPERIDIN; NORVERAPAMIL; VERAPAMIL;

ANIMAL; ARTICLE; BIOAVAILABILITY; BIOLOGICAL MODEL; BIOTRANSFORMATION; BLOOD; DRUG EFFECT; DRUG INTERACTION; FOOD DRUG INTERACTION; INTESTINE ABSORPTION; MALE; ORAL DRUG ADMINISTRATION; RAT; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; BIOTRANSFORMATION; CALCIUM CHANNEL BLOCKERS; DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; HESPERIDIN; INTESTINAL ABSORPTION; MALE; MODELS, BIOLOGICAL; RATS; RATS, SPRAGUE-DAWLEY; VERAPAMIL;

EID: 43049113508     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1187-4     Document Type: Article

References (25)

1. Adachi, Y., Suzuki, H., and Sugiyama, Y., Comparative studies on in vitro methods for evaluating in vivo function of MDR1 P-glycoprotein. Pharm. Res., 18, 1660-1668 (2001).
2. Ameer, B., Weintraub, R. A., Johnson, J. V., Yost, R. A., and Rouseff, R. L., Flavanone absorption after naringin, hesperidin, and citrus administration. Clin. Pharmacol. Ther., 60, 34-40 (1996).
3. Bobrowska-Hagerstrand, M., Wrobel, A., Mrowczynska, L., Soderstrom, T., Shirataki, Y., Motohashi, N., Molnar, J., Michalak, K., and Hagerstrand, H., Flavonoids as inhibitors of MRP1-like efflux activity in human erythrocytes. A structure-activity relationship study. Oncol. Res., 13, 463-469 (2003).
4. Bok, S. H., Lee, S. H., Park, Y. B., Bae, K. H., Son, K. H., Jeong, T. S., and Choi, M. S., Plasma and hepatic cholesterol and hepatic activities of 3-hydroxy-3-methyl-glutaryl-CoA reductase and acyl CoA: cholesterol transferase are lower in rats fed citrus peel extract or a mixture of citrus bioflavonoids. J. Nutr., 129, 1182-1185 (1999).
5. Borradaile, N. M., Carroll, K. K., and Kurowska, E. M., Regulation of HepG2 cell apolipoprotein B metabolism by the citrus flavanones hesperetin and naringenin. Lipids., 34, 591-598 (1999).
6. Choi, J. S. and Burm, J. P., Enhanced nimodipine bioavailability after oral administration of nimodipine with morin, a flavonoid, in rabbits. Arch. Pharm. Res., 29, 333-338 (2006).
7. Choi, J. S. and Han, H. K., Pharmacokinetic interaction between diltiazem and morin, a flavonoid, in rats. Pharmacol. Res., 52, 386-391 (2005).
8. Choi, J. S. and Han, H. K., The effect of quercetin on the pharmacokinetics of verapamil and its major metabolite, norverapamil, in rabbits. J. Pharm. Pharmacol., 56, 1537-1542 (2004).
9. Doppenschmitt, S., Spahn-Langguth, H., Regardh, C. G., and Langguth, P., Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein. J. Pharm. Sci., 88, 1067-1072 (1999).
10. Eichelbaum, M., Mikus, G., and Vogelgesang, B., Pharmacokinetics of (+)-, (-)-and (±)-verapamil after intravenous administration. Brit. J. Clin. Pharmacol., 17, 453-458 (1984).
11. Eichelbaum, M., Remberg, E. G., Schomerus, M., and Dengler, H. J., The metabolism of D,L(14C) verapamil in man. Drug Metab. Dispos., 7, 145-148 (1979).
12. Fleckenstein, A., Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann. Rev. Pharmacol. Toxicol., 17, 149-166 (1977).
13. Fuhr, U., Muller-Peltzer, H., Kern, R., Lopez-Rojas, P., Junemann, M., Harder, S., and Staib A. H. Effects of grapefruit juice and smoking on verapamil concentrations in steady state. Eur. J. Clin. Pharmacol., 58, 45-53 (2002).
14. Garg, A., Garg, S., Zaneveld, L. J. D., and Singla, A. K., Chemistry and pharmacology of the citrus bioflavonoid hesperidin. Phytother. Res., 15, 655-669 (2001).
15. Gottesman, M. M. and Pastan, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62, 385-427 (1993).
16. Gould, B. A., Mann, S., Kieso, H., Bala Subramanian, V., and Raftery, E. B., The 24-hour ambulatory blood pressure profile with verapamil. Circulation., 65, 22-27 (1982).
17. Hodek, P., Trel, P., and Stiborova, M., Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem. Biol. Interact., 139, 1-21 (2002).
18. Kim, H. J. and Choi, J. S., Effects of naringin on the pharmacokinetics of verapamil and one of its metabolites, norverapamil, in rabbits. Biopharm. Drug. Dispos., 26, 295-300 (2005).
19. Korthuis, R. J. and Gute, D. C., Adhesion molecule expression in postischemic microvascular dysfunction: activity of a micronized purified flavonoid fraction. J. Vasc. Res., 36, 15-23 (1999).
20. Lewis, G. R., Morley, K. D., Lewis, B. M., and Bones, P. J., The treatment of hypertension with verapamil. NZ. Medical. J., 87, 351-354 (1978).
21. Ross, J. A. and Kasum, C. M., Dietary avonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr., 22, 19-34 (2002).
22. Schomerus, M., Spiegelhaider, B., Stieren, B., and Eichelbaum, M., Physiologic disposition of verapamil in man. Cardiovasc. Res., 10, 605-612 (1976).
23. Tsai, T. H. and Liu, M. C., Determination of extracellular hesperidin in blood and bile of anaesthetized rats by microdialysis with high-performance liquid chromatography: a pharmacokinetic application. J. Chromatogr. B. Analyt. Technol. Biomed. Life. Sci., 806, 161-166 (2004).
24. Yoshiharu, M., Hitomi, T., Hirotami, M., Mikihiko, N., Takashi, T., Hisakazu, O., and Yasufumi, S., Effect of bioflavonoids on vincristine transport across blood-brain barrier. European Journal of Pharmacology., 395, 193-201 (2000).
25. Zhang, S. and Morris, M. E., Effects of the avonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J. Pharmacol. Exp. Ther., 304, 1258-1267 (2003).